Humanized antibodies against human IL-22RA

Details for Australian Patent Application No. 2010321047 (hide)

Owner Merck Serono S.A.

Inventors Beckmann, Roland; Johnson-Leger, Caroline

Agent FB Rice

Pub. Number AU-A-2010321047

PCT Pub. Number WO2011/061119

Priority 09176525.5 19.11.09 EP; 61/262,998 20.11.09 US

Filing date 12 November 2010

Wipo publication date 26 May 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/061119 Priority application(s): WO2011/061119

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321054-Capsule and method for preparing a beverage such as coffee from said capsule

2010321038-Fluorinated oxa or thia heteroarylalkylsulfide derivatives for combating invertebrate pests